Daiichi Sankyo Company, Limited (DSKYF)
USD 26.5
(0.0%)
USD 26.5
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 250.23 Billion JPY | 43.05% |
| 2023 | 189.6 Billion JPY | 26.25% |
| 2022 | 137.51 Billion JPY | 9.17% |
| 2021 | 134.26 Billion JPY | -19.38% |
| 2020 | 170.63 Billion JPY | 24.89% |
| 2019 | 137.91 Billion JPY | -14.07% |
| 2018 | 131.92 Billion JPY | -9.27% |
| 2017 | 142.87 Billion JPY | -11.65% |
| 2016 | 179.72 Billion JPY | 58.54% |
| 2015 | 125.11 Billion JPY | -19.72% |
| 2014 | 155.85 Billion JPY | -1.57% |
| 2013 | 158.34 Billion JPY | 37.18% |
| 2012 | 95 Billion JPY | -64.99% |
| 2011 | 181.15 Billion JPY | 9.79% |
| 2010 | 158.17 Billion JPY | -52.78% |
| 2009 | 636 Billion JPY | 88.74% |
| 2008 | 209.31 Billion JPY | 79.13% |
| 2007 | 188.11 Billion JPY | -6.06% |
| 2006 | 200.26 Billion JPY | 75.49% |
| 2005 | 114.11 Billion JPY | -7.75% |
| 2004 | 123.7 Billion JPY | 17.04% |
| 2003 | 105.69 Billion JPY | 31.05% |
| 2002 | 80.65 Billion JPY | -8.13% |
| 2001 | 87.79 Billion JPY | -38.48% |
| 2000 | 142.71 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 57.59 Billion JPY | 1218.91% |
| 2024 FY | - JPY | 31.98% |
| 2024 Q3 | 88.24 Billion JPY | 35.37% |
| 2024 Q4 | 32.81 Billion JPY | -62.82% |
| 2024 Q2 | 65.19 Billion JPY | 13.18% |
| 2023 Q4 | 4.36 Billion JPY | -90.88% |
| 2023 FY | - JPY | 26.25% |
| 2023 Q3 | 47.88 Billion JPY | -30.22% |
| 2023 Q2 | 68.61 Billion JPY | 39.8% |
| 2023 Q1 | 49.08 Billion JPY | 237.49% |
| 2022 Q2 | 53.26 Billion JPY | -11.9% |
| 2022 Q1 | 60.45 Billion JPY | 687.9% |
| 2022 Q4 | -35.7 Billion JPY | -167.04% |
| 2022 FY | - JPY | 9.17% |
| 2022 Q3 | 53.25 Billion JPY | -0.01% |
| 2021 Q1 | 56.29 Billion JPY | 3471.02% |
| 2021 Q2 | 40.62 Billion JPY | -27.83% |
| 2021 Q3 | 47.69 Billion JPY | 17.39% |
| 2021 Q4 | -10.28 Billion JPY | -121.56% |
| 2021 FY | - JPY | -19.38% |
| 2020 Q3 | 86.58 Billion JPY | 94.41% |
| 2020 Q2 | 44.53 Billion JPY | -39.77% |
| 2020 Q1 | 73.94 Billion JPY | 60509.02% |
| 2020 FY | - JPY | 24.89% |
| 2020 Q4 | -1.67 Billion JPY | -101.93% |
| 2019 Q4 | 122 Million JPY | -99.77% |
| 2019 Q3 | 53.57 Billion JPY | 29.2% |
| 2019 Q2 | 41.46 Billion JPY | -4.53% |
| 2019 FY | - JPY | -14.07% |
| 2019 Q1 | 43.43 Billion JPY | 1973.9% |
| 2018 Q2 | 21.01 Billion JPY | -61.29% |
| 2018 Q4 | -2.31 Billion JPY | -103.92% |
| 2018 Q3 | 59.19 Billion JPY | 181.67% |
| 2018 FY | - JPY | -9.27% |
| 2018 Q1 | 54.28 Billion JPY | 310.7% |
| 2017 Q4 | -25.76 Billion JPY | -135.02% |
| 2017 Q3 | 73.57 Billion JPY | 94.17% |
| 2017 Q2 | 37.89 Billion JPY | -36.67% |
| 2017 Q1 | 59.83 Billion JPY | 875.63% |
| 2017 FY | - JPY | -11.65% |
| 2016 Q1 | 61.14 Billion JPY | 247.5% |
| 2016 Q4 | -7.71 Billion JPY | -111.56% |
| 2016 FY | - JPY | 58.54% |
| 2016 Q3 | 66.73 Billion JPY | 12.04% |
| 2016 Q2 | 59.55 Billion JPY | -2.59% |
| 2015 FY | - JPY | -19.72% |
| 2015 Q2 | 40.11 Billion JPY | -10.09% |
| 2015 Q3 | 57.15 Billion JPY | 42.49% |
| 2015 Q4 | -41.45 Billion JPY | -172.52% |
| 2015 Q1 | 44.61 Billion JPY | 25.81% |
| 2014 Q3 | 68.68 Billion JPY | 35.86% |
| 2014 Q1 | 34.28 Billion JPY | 1705.37% |
| 2014 FY | - JPY | -1.57% |
| 2014 Q4 | 35.46 Billion JPY | -48.37% |
| 2014 Q2 | 50.55 Billion JPY | 47.46% |
| 2013 Q2 | 17.16 Billion JPY | -52.94% |
| 2013 Q4 | 1.89 Billion JPY | -95.37% |
| 2013 FY | - JPY | 37.18% |
| 2013 Q1 | 36.46 Billion JPY | -78.84% |
| 2013 Q3 | 40.98 Billion JPY | 138.82% |
| 2012 FY | - JPY | -64.99% |
| 2012 Q1 | 46.85 Billion JPY | -17.54% |
| 2012 Q2 | 94.59 Billion JPY | 101.91% |
| 2012 Q3 | -47.82 Billion JPY | -150.55% |
| 2012 Q4 | 172.3 Billion JPY | 460.31% |
| 2011 Q3 | 84.74 Billion JPY | 10.24% |
| 2011 FY | - JPY | 9.79% |
| 2011 Q4 | 56.81 Billion JPY | -32.96% |
| 2011 Q2 | 76.87 Billion JPY | -0.1% |
| 2011 Q1 | 76.95 Billion JPY | 23.63% |
| 2010 Q2 | 75.96 Billion JPY | 7.55% |
| 2010 Q3 | 91.48 Billion JPY | 20.43% |
| 2010 Q4 | 62.24 Billion JPY | -31.97% |
| 2010 FY | - JPY | -52.78% |
| 2010 Q1 | 70.63 Billion JPY | 46.28% |
| 2009 Q2 | 54.43 Billion JPY | 0.0% |
| 2009 Q3 | 440.75 Billion JPY | 709.65% |
| 2009 Q4 | 48.28 Billion JPY | -89.05% |
| 2009 FY | - JPY | 88.74% |
| 2008 FY | - JPY | 79.13% |
| 2007 FY | - JPY | -6.06% |
| 2006 FY | - JPY | 75.49% |
| 2005 FY | - JPY | -7.75% |
| 2004 FY | - JPY | 17.04% |
| 2003 FY | - JPY | 31.05% |
| 2002 FY | - JPY | -8.13% |
| 2001 FY | - JPY | -38.48% |
| 2000 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AstraZeneca PLC | 13.28 Billion USD | -1782.932% |
| Bristol-Myers Squibb Company PFD CONV 2 | 19.41 Billion USD | -1188.742% |
| CSPC Pharmaceutical Group Limited | 1.14 Billion USD | -21696.237% |
| Clarus Therapeutics Holdings, Inc. | -39.7 Million USD | 630335.487% |
| Novartis AG | 19.51 Billion USD | -1182.084% |
| PT Kalbe Farma Tbk. | 288.13 Million USD | -86746.84% |